Ariel Israel1, Shaye Kivity2, Yechezkel Sidi3, Shlomo Segev4, Anat Berkovitch5, Robert Klempfner5, Bruno Lavi6, Ilan Goldenberg7, Elad Maor8. 1. Leviev Heart Centre, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel Clalit Health Services, Jerusalem, Israel. 2. Department of Internal Medicine C, Chaim Sheba Medical Centre, Tel-Hashomer, Israel Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Centre, Tel-Hashomer, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. 3. Department of Internal Medicine C, Chaim Sheba Medical Centre, Tel-Hashomer, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. 4. Institute for Medical Screening, Chaim Sheba Medical Centre, Tel-Hashomer, Israel. 5. Leviev Heart Centre, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel. 6. Medical Center Management, Chaim Sheba Medical Centre, Tel-Hashomer, Israel. 7. Leviev Heart Centre, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. 8. Leviev Heart Centre, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Centre, Tel-Hashomer, Israel eladmaor@gmail.com elad.maor@sheba.health.gov.il.
Abstract
AIMS: The SCORE risk estimation system is used for cardiovascular risk stratification in apparently healthy adults and is based on known cardiovascular risk factors. The purpose of the current study was to evaluate whether exercise capacity can improve the accuracy of the SCORE overall survival risk estimation. METHODS AND RESULTS: We investigated 22 878 asymptomatic men and women who were annually screened in a tertiary medical centre. All subjects were free of known ischaemic heart disease, and had completed maximal exercise stress test according to the Bruce protocol. The SCORE risk estimation system was used to evaluate individual cardiovascular risk for all subjects. The primary endpoint was mortality, after exclusion of patients with metastatic cancer during follow-up. The incremental contribution of exercise capacity in predicting the risk of death was evaluated by net reclassification improvement (NRI) and area under the receiver operating curve (AUROC). Mean age of the study population was 47.4 ± 10.3, and 71.6% were men. There were 505 (2.21%) deaths during a mean follow-up of 9.2 ± 4.1 years. Kaplan-Meier survival analysis showed that both SCORE and low exercise capacity were associated with reduced survival. When added to the SCORE risk prediction, exercise capacity allowed more accurate risk stratification: NRI analysis showed an overall improvement of 56.8% in the accuracy of classification and the AUROC increased (0.782 vs. 0.766). CONCLUSION: Both SCORE and exercise capacity are strong independent predictors of all-cause mortality. The addition of exercise capacity to the SCORE risk model can improve the accuracy of the model. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The SCORE risk estimation system is used for cardiovascular risk stratification in apparently healthy adults and is based on known cardiovascular risk factors. The purpose of the current study was to evaluate whether exercise capacity can improve the accuracy of the SCORE overall survival risk estimation. METHODS AND RESULTS: We investigated 22 878 asymptomatic men and women who were annually screened in a tertiary medical centre. All subjects were free of known ischaemic heart disease, and had completed maximal exercise stress test according to the Bruce protocol. The SCORE risk estimation system was used to evaluate individual cardiovascular risk for all subjects. The primary endpoint was mortality, after exclusion of patients with metastatic cancer during follow-up. The incremental contribution of exercise capacity in predicting the risk of death was evaluated by net reclassification improvement (NRI) and area under the receiver operating curve (AUROC). Mean age of the study population was 47.4 ± 10.3, and 71.6% were men. There were 505 (2.21%) deaths during a mean follow-up of 9.2 ± 4.1 years. Kaplan-Meier survival analysis showed that both SCORE and low exercise capacity were associated with reduced survival. When added to the SCORE risk prediction, exercise capacity allowed more accurate risk stratification: NRI analysis showed an overall improvement of 56.8% in the accuracy of classification and the AUROC increased (0.782 vs. 0.766). CONCLUSION: Both SCORE and exercise capacity are strong independent predictors of all-cause mortality. The addition of exercise capacity to the SCORE risk model can improve the accuracy of the model. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs Journal: Circulation Date: 2010-11-15 Impact factor: 29.690
Authors: C Foster; A S Jackson; M L Pollock; M M Taylor; J Hare; S M Sennett; J L Rod; M Sarwar; D H Schmidt Journal: Am Heart J Date: 1984-06 Impact factor: 4.749
Authors: Gary J Balady; Martin G Larson; Ramachandran S Vasan; Eric P Leip; Christopher J O'Donnell; Daniel Levy Journal: Circulation Date: 2004-09-27 Impact factor: 29.690
Authors: R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham Journal: Eur Heart J Date: 2003-06 Impact factor: 29.983
Authors: Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad Journal: Eur Heart J Date: 2012-05-03 Impact factor: 29.983
Authors: Karsten Königstein; Jonathan Wagner; Denis Infanger; Raphael Knaier; Gilles Nève; Christopher Klenk; Justin Carrard; Timo Hinrichs; Arno Schmidt-Trucksäss Journal: Front Cardiovasc Med Date: 2022-04-28
Authors: Emilian Zadarko; Maria Zadarko-Domaradzka; Zbigniew Barabasz; Marek Sobolewski Journal: Int J Environ Res Public Health Date: 2022-02-24 Impact factor: 3.390